Friday, March 30, 2012

Take a hard look at your financial life before assuming you're ready

As we approach the end of 2010, it�s only natural to get philosophical about the promise a New Year. But if your plans for the next 12 months involve retirement, you had better be doing more than just day-dreaming of shuffleboard and visits to the grandkids. Retiring is serious business and requires even more planning than your working life did.
Before you offer up a toast over the holidays promising your pending retirement, take a hard look in the mirror. There are a number of telltale signs that you may not be ready to quit working and live on a fixed income just yet.
Here are 11 signs that you won�t be retiring in 2011:
1. You Have Set a Date With Death. There is nothing more morbid than an investor or would-be retiree who only plans for a finite retirement, writing off the need for further funds since they don�t expect to live any longer than an allotted time. To begin with, modern medicine continues to extend American lives and the quality of those lives. Unless your zero hour for retirement occurs at 90 or 100 years old, I would humbly suggest you revisit your retirement budget — if not for your sake, for the sake of the family members who will be stuck with you otherwise.
2. You Never Worry About Scams. The ubiquitous actor Kevin Bacon has never been one to turn down a role, but after losing $50 million to Bernie Madoff he will surely be working hard in Hollywood for many more years to come if he plans on retiring comfortably. The unfortunate fate of the Footloose star should have set off warning bells in your head to check your account balances as soon as possible. If you�re still just taking your investment adviser�s word for it when it comes to your account balances, you better pick up the phone today and have a nice chat with him.
3. You Have Credit Card Debt. It�s no surprise that with over 30% of 65- to 74! -year-ol ds carrying a balance on their credit cards, bankruptcy rates for Americans over 65 skyrocketed 150% between 1991 and 2007, according to the Consumer Bankruptcy Project. Besides, paying off your credit card and living within your means is good practice for living on a fixed income. Put simply: The more debt you have, the less secure your retirement will be. Unless you have a huge nest egg you should concentrate on eroding your balances before you quit the workforce.
4. You�re Still Supporting Your Family. If Junior lost his job recently and has been living in your basement while he looks for work yet, you won�t be retiring in 2011. Similarly, if you�re in your 50s and looking after your parents who haven�t adequately provided for their own retirement, you�re out of luck. The bottom line is that living on a fixed income is hard enough for an individual or a couple without the added uncertainty of third and fourth parties.
5. You Don�t Know What Your Social Security Benefits Will Be — Or Won�t Be. It�s bad enough not knowing what you�ll receive each month from Social Security. But it�s even worse if you haven�t thought about how the timing of your retirement will affect benefits. Let�s say you�re making $50,000 and were born in 1951. If you decided for �early� retirement next year (age 62 is early according to the Social Security Administration), your benefits would total roughly $1,042 a month. On the other hand if you worked another four years you�ll make nearly $400 more a month — $1,439. And if you somehow stay in the workforce until 70, you�ll make almost twice as much — $1,991 a month. These are just estimates of course, calculated via a free online SSA tool, but you can see that timing plays a huge role in your Social Security payout.
6. You Have a Significant Mortgage Balance. Significant is a vague term, but all retirement planning is subjective. The bottom line is that it�s best to pay off your mortgage if you ! can R 12; in large part because it�s one less thing to worry about when setting a budget. Also, tax advantages of home ownership are slim to none as you approach the end of your mortgage amortization schedule, since payments are almost wholly principle.
7. You Don�t Have a Budget. Even if you know what cash is coming in from the government, that information is useless if you don�t have a plan for the money going out. Once you embark on retirement, it�s very difficult to come up with new sources of income later on if you budget breaks down. Make sure you don�t find that out the hard way by projecting all your expenses.
8. Your Budget Depends on Investments Appreciating or Paying Dividends. Anyone planning to retire in 2009 on stock market profits learned a hard lesson that investments cut both ways. After GM went bankrupt and major banks gutted or outright eliminated their dividends, all would-be-retirees would be wise to not count their chickens before they�re hatched. If you don�t actually have the money locked in to retire in 2011, you shouldn�t retire. Period. And with the specter of inflation on the horizon, even �sure thing� income investments like bonds may fail to grow your nest egg as yields get eclipsed by a rising cost of living.
9. Your Budget Doesn�t Cover Medical Expenses. Retiree medical coverage is a dinosaur among employer benefits, rapidly approaching extinction. If you�re planning to retire before 65, you better be aware that Medicare doesn’t kick in until then. And be prepared for the harsh reality that as a member of an older demographic with higher risk, you may have to pay out the nose — or worse, that some insurers may refuse to cover you. Even after age 65 there are options and expenses to weigh, such as the difference between traditional Medicare vs. Medicare Advantage or the benefits of private �Medigap� supplemental insurance. Health care is becoming increasingly expensive, and thus an increasingly impor! tant par t of retirement planning.
10. Your Retirement Plan is Just a Plan. So you�ve done the math and made the plan. Good for you. But if your retirement involves a significant change in routine or scenery, you better test the water before diving in. If you�re moving to a retirement community or getting a second home in the South for winter, get to know the neighborhood and surroundings before you�re locked into a rental agreement or property you may regret. If you�ve only planned visit the grandkids every few weeks, think about how you�ll fill the other 26 or 27 days in the month and take a few preparatory trips to get used to the travel arrangements. It does no good to set a budget and a schedule if they make you miserable, so make sure you give your new life a trial run. Retirement on paper and reality can be quite different.
11. You Love Your Job. This last point hits close to home. My father David is a fire chief for Syracuse, New York, and thanks to a plush government pension and simple tastes he could retire tomorrow in style — if you consider a beach chair, a book and a cigar stylish. But he won�t. For 30-plus years he�s worked for the city�s fire department and I�m sure he would work another 30 if my mom and his health will let him. So as much as you like to talk about quitting Dad, you�re not retiring in 2011. And we both know it.
Jeff Reeves is editor of InvestorPlace.com. Follow him on Twitter at http://twitter.com/JeffReevesIP.

Thursday, March 29, 2012

Maximize Your Forex Profits: Use a Simple but Powerful and Effective Forex Trading System

You might have heard of Forex, but did you realize that one of the fastest developing markets is foreign exchange trading? Forex trading can be done from the comfort of your home while sitting in your favorite recliner, but you can also make trades from just about anywhere else you’d like to do it. Forex, or “foreign exchange trading,” is trading in currency pairs and does not involve the more typical trading in stocks or bonds. Although now exploding in popularity, Forex trading only became available to individuals a few years ago. In fact, the Internet’s speed is what made it possible for people to trade in the Forex market. Before the Internet, manually placing trades at precisely the right times was almost impossible because Forex is such a fast-paced market.
Different Forex trading systems have been developed by forex traders to ensure their success by helping them buy and sell at ideal times. However, in some ways these systems are similar: almost all of them use a combination of fundamental and technical analysis. The condition of a specific currency’s country, meaning its social, political and economic stability, is evaluated in the fundamental analysis. The greater the stability of a particular currency’s country, the more stable that country’s currency is likely to be. And the greater the stability of the currency, the more valuable the currency will be.
Technical analysis focuses on trends; how well has a particular currency been doing in the past, and therefore, what is its forecasted performance for the future? By utilizing both of these types of analysis to determine how well a particular currency is likely to do, you can determine how much you should trust a particular currency, which will in turn determine how you trade.
There are also different systems within technical analysis, in particular. One particular Forex System that’s very simple and yet can give the maximum Forex Profit uses the “simple moving average&#! 8221; of a particular currency. It’s called the “three duck” system. With Duck Number 1, you look at the four hour time frame and see if the currency’s car prices are above or below the 60 “simple moving average,” or SMA. If it is already below 60, you may want to look to sell for a sell short. With Duck Number 2, you break it down further, and go down to the one-hour chart, a shorter timeframe than with “Duck 1.” If the current price is still below the 60 SMA then things are looking good for a sell short, “our ducks are getting in a row”, this is further confirmation that you should sell. Finally, with Duck Number 3, you break things down even further and look at the five-minute chart. What if the price drops below the 60 SMA? If prices go below the 60 SMA and for all three “ducks,” then you have a sell short signal.
Using stop losses can also be an effective forex trading strategy. These tools can help a trader decide when to sell. For example, as a positional trader you can go for the high on the four-hour chart, or you can use a simple fixed stop loss and set a point from entry, such as 30 pips.
Whatever you choose, make sure the system you choose is something you are going to understand and be able to make quick decisions with. A simple system that you truly understand and trust is going to help you keep your emotions out of your trades, too, which is imperative if you want to be a successful trader. Don’t stay in trades in hopes that you’ll make more if you’re profiting, even though your analyses tell you that you should get out, and don’t stay on in hopes that you’re going to make back losses.
When you are first starting out, do take advantage of the tools Forex brokers give you so that you can ease on in and start slow. First, practice before you trade with real money. Most Forex brokers will let you open a demo account so that you can practice se! eing wha t currency trends look like, when to get in and out of trades, how to place stop loss orders, and so on. And when you’re ready, most Forex brokers will also let you trade with very small amounts of money so that you’re not risking much when you trade. In fact, many in Forex traders will you begin your trades with as little as $10. It’s true that your profits will be small, but so will your losses.
There’s one last thing you should always keep in mind: never trade with money you can’t afford to lose. An effective Forex trading system will help you maximize your profits on the Forex market, but sometimes you will lose. Be mentally prepared for these inevitable losses, and only trade with money you can afford to lose. Learn how the Forex market operates first, always make sure your trades are affordable, and then make sure you’re comfortable with them. You can do all of this and maximize your Forex profits by using a simple but powerful and effective Forex trading system.
Learn more about Forex Training programs that work. Bill Shur recommends this site where you can get the bestForex Trading System and what it can do for you.
categories: forex trading system, forex trading strategy, forex system, forex strategy, forex training, learn forex, forex course, forex profit, forex signals, online currency trading, currency trading, forex market, foreign exchange trading, fx trading

Wednesday, March 28, 2012

Gildan Activewear Hits Estimates in Solid Quarter

Gildan Activewear (NYSE: GIL  ) reported earnings on Feb. 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Jan. 1 (Q1), Gildan Activewear met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted and GAAP earnings per share dropped to a loss.
Margins dropped across the board.
Revenue details
Gildan Activewear logged revenue of $303.8 million. The 11 analysts polled by S&P Capital IQ predicted revenue of $302.1 million. GAAP sales were 8.3% lower than the prior-year quarter's $331.3 million.
anImage
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at -$0.38. The 13 earnings estimates compiled by S&P Capital IQ averaged -$0.38 per share. GAAP EPS were -$0.38 for Q1 against $0.29 per share for the prior-year quarter.
anImage
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 2.1%, 2,260 basis points worse than the prior-year quarter. Operating margin was -14.6%, 2,670 basis points worse than the prior-year quarter. Net margin was -15.2%, 2,600 basis points worse than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $426.6 million. On the bottom line, the average EPS estimate is $0.19.
Next year's average estimate for revenue is $1.94 billion. ! The aver age EPS estimate is $1.30.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 246 members out of 258 rating the stock outperform, and 12 members rating it underperform. Among 88 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give Gildan Activewear a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gildan Activewear is outperform, with an average price target of $22.51.
With hundreds of companies like Gildan Activewear competing for shoppers' limited dollars, strong brands matter. Household names can provide growth for even boring, mature companies -- as long as you choose the right ones. Learn about a few who have what it takes in "3 American Companies Set to Dominate the World." Click here for instant access to this free report.
  • Add Gildan Activewear to My Watchlist.

Best Wall St. Stocks Today: GD,VALE,GMCR,GLW,CHK,ARG,ACAT,BMY,CY,LMT,MKC,MWW,POT,RTN,VIST,TMP,RNWK,INTC,MNTA,NFLX,EFSC

All three major US indexes opened higher this morning, but enthusiasm tapered off quickly and steadily, if not sharply. A drop in the number of new home sales and a smaller-than-expected rise in the leading economic indicators index. Hope that talks between Greece and its creditors would yield an agreement also pushed markets higher. But the weak housing report and no further news from Europe kept share prices moving down. WTI crude gained 0.35% at $99.75/barrel and Brent crude is up 1.02% at $110.93. Gold is higher by 1.27% at $1,724.60.
The unofficial closing bells put the DJIA down more than 22 points to 12,734.63 (-0.18%), the NASDAQ fell about 13 points (-0.46%) to 2,805.28, and the S&P 500 fell -0.57% or nearly 7 points to 1,318.45.
There were several analyst upgrades and downgrades today, including General Dynamics Corp. (NYSE: GD) cut to �perform� at Oppenheimer; Vale S.A. (NYSE: VALE) cut to �hold� at Deutsche Bank; Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR) started as �perform� at Williams Capital; Corning Inc. (NYSE: GLW) cut to �underweight� at Morgan Stanley; and Chesapeake Energy Corp. (NYSE: CHK) cut to �underweight� at JPMorgan.
Earnings reports since markets closed on last night have led to some price changes as of the last half hour of trading today: Airgas Inc. (NYSE: ARG) is down -3.66% at $77.29; Arctic Cat Inc. (NASDAQ: ACAT) is up more than 19% at $28.40 after posting a new 52-week high of $29.20 earlier today; AT&T Inc. (NYSE: T) is down -2.65% at $29.41; Bristol-Myers Squibb Co. (NYSE: BMY) is down -0.92% at $32.40; Caterpillar Inc. (NYSE: CAT) is up 1.95% at $111.18; Cypress Semiconductor Corp. (NASDAQ: CY) is down more than -11% at $17.03; Lockheed Martin Corp. (NYSE: LMT) is up 0.95% at $82.51; McCormick & Co. Inc. (NYSE: MKC) is up 0.90% at $78.55; Monster Worldwide Inc. (NYSE: MWW) is down more than -20% at $7.18; Potash Corp. of Saskatchewan Inc. (NYSE: POT) is up 1.61% at $45.96; and Raytheon Co. (NYSE: RTN) is up 0.34% at $49.88.
Other standouts from today include the following stocks:
VIST Financial Corp. (NASDAQ: VIST) is up more than 62% at $11.20 after posting a new 52-week high of $11.50 earlier today. The bank holding company has agreed to be acquired by Tompkins Financial Corp. (AMEX: TMP) in an all-stock deal at an 86% premium to last night�s closing price, or about $85 million.
RealNetworks Inc. (NASDAQ: RNWK) is up more than 35% at $9.98. The digital media company has sold a video codec and a number of patents to Intel Corp. (NASDAQ: INTC) for $120 million.
Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) is down nearly -21% at $15.13. The biotechnology company lost its bid for an injunction against certain competitors.
Netflix Inc. (NASDAQ: NFLX) is up about 22% at $116.01. The digital video streaming and rental company reported a better-than-expected number of new subscribers after markets closed last night.
Enterprise Financial Services Corp. (NASDAQ: EFSC) is down more than -19% at $12.51. The bank holding company will restate earnings for 2010 and the first three quarters of 2011 and expects to dilute 2010 earnings by half as a result.
Stay tuned for Friday. New York Fed President William Dudley is giving a speech in the morning. We have noted the following events on the schedule (all times Eastern):
  • 8:30 a.m. – US GDP report
  • 9:55 a.m. – Reuters/University of Michigan consumer sentiment index

Monday, March 26, 2012

Top Stocks To Buy 2015

If you want to know what stocks to buy in this uncertain market, here's a proven strategy.

Take a good look around at the products and services you use. Assess what's working, what's most important to you and what you refuse to give up even when times are tough.

Then consider that the companies whose products you know and love might also be stocks you'll love as an investor.

After all, from the time you sip your morning coffee to the moment you retire for the night on your memory-foam mattress, you're doing consumer research. That's especially true these days, when you're watching every dollar and talking with your friends about what products give you the most bang for the buck.

In short, don't ignore that experience. Use it to get a leg up on the professionals.

Sure, the folks on Wall Street have lightning-fast computers and armies of analysts. But they don't necessarily have a better read on consumers than you do. Because they don't make the same choices people on Main Street do.

Top Stocks To Buy 2015:J.B. Hunt Transport Services Inc. (JBHT)

 J.B. Hunt Transport Services, Inc., together with its subsidiaries, operates as a surface transportation, delivery, and logistics company in North America. It operates in four segments: Intermodal (JBI), Dedicated Contract Services (DCS), Full-Load Dry-Van (JBT), and Integrated Capacity Solutions (ICS). The JBI segment provides intermodal freight solutions, including origin and destination pickup and delivery services in the continental United States, Canada, and Mexico. This segment operates 45,666 pieces of company-controlled trailing equipment; and manages a fleet of 2,592 company-owned tractors. The DCS segment involves in the design, development, and execution of supply chain solutions, which support various transportation networks. This segment offers final mile delivery, replenishment, and specialized services supporting private fleet conversion, fleet creation, and transportation system augmentation. As of December 31, 2010, it operated 4,259 company-owned trucks, 357 customer-owned trucks, and 23 independent contractor trucks. The JBT segment provides full-load, dry-van freight services by utilizing tractors operating over roads and highways. It operated 1,697 company-owned tractors. The ICS segment provides non-asset, asset-light, and transportation logistics solutions. It offers flatbed, refrigerated, expedited, and less-than-truckload, as well as various dry-van and intermodal solutions. The company transports a range of freight, including general merchandise, specialty consumer items, appliances, forest and paper products, building materials, soaps and cosmetics, automotive parts, electronics, and chemicals. J.B. Hunt Transport Services, Inc. was founded in 1961 and is headquartered in Lowell, Arkansas.

Top Stocks To Buy 2015:Cincinnati Bell Inc (CBB)

 Cincinnati Bell Inc., together with its subsidiaries, provides telecommunications and technology services. The company?s Wireline segment provides local voice services, including local telephone service, switched access, and value-added services, such as caller identification, voicemail, call waiting, and call return; data services comprising high-speed Internet using digital subscriber line technology, fiber to the home, dial-up Internet access, network access, and gigabit Ethernet and asynchronous transfer mode data transport services. This segment?s services also comprise long distance and voice over Internet protocol (VoIP)services, such as long distance voice, audio conferencing, VoIP, and other broadband services; entertainment services that consist of television over fiber optic cable and coaxial cable in limited areas, and DirecTV commissioning over the company?s operating area; and other services consisting of security monitoring, inside wire installation for business enterprises, rental revenue of space, public payphones, and clearinghouse services. It?s Wireless segment provides advanced digital wireless voice and data communications services through the wireless network in a licensed service territory, which includes Greater Cincinnati and Dayton, Ohio, and areas of northern Kentucky and southeastern Indiana. This segment offers postpaid and prepaid wireless subscription services; and wireless handset devices to customers to use its wireless services. The company?s Data Center Colocation segment provides data center colocation services to businesses. This segment operates 17 data centers with 639,000 square feet of total data center space in Texas, Ohio, Kentucky, Indiana, Michigan, and Illinois. It?s IT Services and Hardware segment offers a range of managed IT solutions, including managed infrastructure services, IT and telephony equipment sales, and professional IT staffing services. The company was founded in 1873 and is based in Cincinnati, Ohio.

Top Stocks To Buy 2015:Mad Catz Interactive Inc (MCZ)

 Mad Catz Interactive, Inc. designs, manufactures, markets, sells, and distributes accessories for videogame platforms and personal computers (PC), as well as for iPod and other audio devices. Its products include videogame, PC, and audio accessories, such as control pads, video cables, steering wheels, joysticks, memory cards, light guns, flight sticks, dance pads, microphones, car adapters, carry cases, mice, keyboards, and headsets. It markets its products primarily under the Mad Catz, Saitek, Cyborg, Eclipse, Joytech, GameShark, Tritton, and AirDrives brands. The company also develops flight simulation software; operates flight simulation centers under its Saitek brand; operates a videogame content Website under its GameShark brand; publishes games under its Mad Catz brand; and distributes games and videogame products for third parties. It distributes its products through retailers in the United States, Europe, and Canada, as well as in Australia, Japan, Korea, New Zealand, and Singapore. The company was founded in 1989 and is headquartered in San Diego, California

Top Stocks To Buy 2015:Alliance One International Inc. (AOI)

 Alliance One International, Inc. engages in purchasing, processing, storing, and selling leaf tobacco to cigarette manufacturers and other consumer tobacco products worldwide. The company primarily involves in the processing and sale of flue-cured, burley, and oriental tobaccos. It also provides agronomy services for growing leaf tobacco. Alliance One International, Inc. was founded in 1904 and is headquartered in Morrisville, North Carolina.

Top Stocks To Buy 2015:Precision Castparts Corporation (PCP)

 Precision Castparts Corp. (PCC) manufactures and sells metal components and products worldwide. Its Investment Cast Products segment offers aerospace structural and airfoil castings; industrial gas turbine (IGT) castings; artificial hips and knees; parts for satellite launch vehicles; landing gear struts and engine inlets for unmanned aerial vehicles; impellers for pumps and compressors; components for armament systems; and alloys for other manufacturers of investment castings. The company?s Forged Products segment provides forged components for jet engines, including fan discs, compressor discs, turbine discs, seals, spacers, shafts, hubs, and cases; airframe structural components, such as landing gear beams, bulkheads, wing structures, engine mounts, struts, tail flaps, and housings; discs, spacers, and valve components for steam turbine and IGT engines; shafts, cases, and compressor and turbine discs for marine gas engines; mechanical and structural tubular forged products for energy markets; and forged components for propulsion systems on nuclear submarines and aircraft carriers, as well as forgings for pumps, valves, and structural applications. PCC?s Fastener Products segment offers aerospace fasteners comprising bolts, nuts, nut plates, latches, expandable diameter fasteners, quick release pins, hydraulic fittings, bushings, inserts, collars, and other precision components. It also provides refiner plates and screen cylinders for the pulp and paper industry; metal-injection-molded and ThixoFormed components; grinder pumps and components for sewer systems; gas monitoring systems for the power generation industry; and thread-rolling and trimming dies, pins and steel, and carbide forging tools for fastener production. PCC sells its fastener products and services through a network of distributors and independent sales representatives, as well as through a direct sales and marketing staff. The company was founded in 1949 and is based in Portland, Oregon.

Top Stocks To Buy 2015:MarkWest Energy Partners LP (MWE)

 Markwest Energy Partners, L.P., together with its subsidiaries, engages in the gathering, processing, and transportation of natural gas. The company also transports, fractionates, storages, and markets natural gas liquids; and gathers and transports crude oil, as well as owns a crude oil transportation pipeline in Michigan. It conducts its operations in the Southwest, the Northeast, Liberty, and the Gulf Coast. MarkWest Energy GP, L.L.C. serves as the general partner of the company. MarkWest Energy Partners, L.P. was founded in 1988 and is based in Denver, Colorado.

Top Stocks To Buy 2015:American Express Company (AXP)

 American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company?s product portfolio consists of charge and credit card products; expense management products and services; consumer and business travel services; stored value cards, including travelers cheques and other prepaid products; network services; merchant acquisition and processing, point-of-sale, servicing and settlement, and marketing and information products and services for merchants; and fee services comprising market and trend analyses and related consulting services, fraud prevention services, and the design of customer loyalty and rewards programs. In addition, it publishes luxury lifestyle magazines; business and travel resources; general interest, cooking, travel, wine, cocktail, financial, and time management books; and international and electronic editions. The company sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through direct mail, on-line applications, targeted direct and third-party sales forces, and direct response advertising worldwide. American Express Company was founded in 1850 and is headquartered in New York, New York.
Advisors' Opinion:
  • By Quickel At 2011-10-30
    Legg Mason Capital Management held $288 Million AXP shares on December 31st 2010. The stock holdings are almost unchanged since the end of September and it returned 8.1% since then. American Express gained 20.3% during the past 1 year, slightly underperforming the SPY.
  • By Jim Cramer At 2011-9-7
    American Express (AXP) just doesn't get the rewards it deserves in this market with people constantly trying to lump it in with slow growth banks or Visa (V) and MasterCard (MA) which have been whacked by! the Fed because of debit fees. American Express is a credit card company with fewer and fewer defaults and excellent growth, especially with the rebounding world economy, and it should be treated as such. I see the company earning $4 next year and deserving a 15 multiple, more in keeping with double-digit growth companies. Call it $60.

Top Stocks To Buy 2015:Bio-Rad Laboratories Inc. (BIO)

 Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets worldwide with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, sells, and services reagents, apparatus, and instruments used for biological research. This segment sells its products to university and medical school laboratories, pharmaceutical and biotechnology companies, food testing laboratories, and government and industrial research facilities. The Clinical Diagnostics segment develops, manufactures, sells, and services automated test systems, informatics systems, test kits, and specialized quality controls for the healthcare market. This segment sells its products to reference laboratories, hospital laboratories, screening facilities, physicians? office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company was founded in 1952 and is headquartered in Hercules, California.

Sunday, March 25, 2012

Best Wall St. Stocks Today: SBUX

No one on Wall St. liked the Starbucks (SBUX) quarterly results and the shares moved down after they were announced. They still sit close to a 52-week low. The company reported revenues of $2.8 billion, a 17 percent increase from fiscal Q1 of 2007. Earnings per share were $0.28, compared to $0.26 per share in the period a year ago. Comparable store sales growth of one percent worldwide.
The company’s solution to these problems seems to have three pieces. First, Starbucks will sell a $1 cup of coffee. It may bring in foot traffic, but probably won’t be profitable. Second, the company will eliminate selling sandwiches.
Finally, Starbucks will close 100 stories in the US. That is out of a total of 11,168 in the US at of the end of 2007, which is up from 9,401 at the end of 2006. In the US, same-store sales fell 1% in the last quarter.
Howard Schultz is back as Starbucks CEO and there is already something wrong with his math. Shareholders are bleeding and the company is planning to close 100 under-performing stores out of a universe of over 11,000.
If Starbucks is going to get back in the good graces of investors, it is going to have to look at a program significantly more radical than the one it proposes. It is plain to almost everyone except the company that with shrinking same-store sales a .1% reduction in locations is not even close to adequate.
But, Schultz has already fired his CEO, and he is unlikely to do the same thing to himself.

Friday, March 23, 2012

(ALN, IDN, CLNO, VRNG) Stock Report from DrStockPick.com

American Lorain Corporation (AMEX:ALN) announced financial results for its second quarter ended June 30, 2011. Q2 2011 Financial Highlights: Total revenues of $35.7 million, an increase of 22.3% year over year, Gross margins decreased slightly to 21.4%, compared to 23.0% year-over-year and 22.7% at 12/31/2010, Net income attributable to common stockholders of $3.3 million, up 21.8% year-over-year & Diluted earnings per share of $0.09.
American Lorain Corporation develops, manufactures, and sells various food products in China and internationally.
Intellicheck Mobilisa, Inc. (AMEX:IDN) announced that ports in New York City have purchased the Company’s IM2700 mobile Transportation Worker Identity Credential (TWIC) reader system. The customer, a global energy management specialist, operates port facilities in and around Manhattan. In its efforts to increase port security without impacting port operations, the customer purchased Intellicheck Mobilisa’s handheld TWIC reader, which reads, validates and authenticates the government-mandated TWIC card.
Intellicheck Mobilisa, Inc. develops and markets wireless technology and identity systems for mobile and handheld wireless devices for the government, military, and commercial markets.
Cleantech Transit, Inc. (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirem! ent to s ecure the Company’s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
Biomass is any recent plant or animal organic matter. Coal and oil fossil fuels are fossilised biomass. Biomass energy can be produced from plants, wood, residues (for example sawdust and bagasse, or sugar cane residue, after crushing) and animal wastes. During photosynthesis, solar energy and carbon dioxide are stored in plants. When biomass is burned carbon dioxide and energy are released, which is the reverse of photosynthesis.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
Vringo, Inc. (AMEX:VRNG) announced it has launched its Facetones product with Nokia (NYSE:NOK) the world’s largest manufacturer of mobile phones. Vringo’s innovative new Facetones product will be available to Symbian users through the Ovi Store, the mobile app portal operated by Nokia.
Vringo, Inc., a development stage company, provides software platforms for mobile video applications and video ringtones.

Wednesday, March 21, 2012

U.S. stock futures higher ahead of jobless claims

MARKETWATCH FRONT PAGE

U.S. stock futures trade slightly higher on Thursday as investors awaited a closely watched report on weekly jobless claims See full story.

Housing takes another step out of the cellar

Housing looks to be climbing out of the sub-basement, but it�s a long way from heading up the stairs to expansion, writes Kathleen Madigan. See full story.

Housing takes another step out of the cellar

Housing looks to be climbing out of the sub-basement, but it�s a long way from heading up the stairs to expansion, writes Kathleen Madigan. See full story.

Housing recovery for real? Deutsche Bank says yes

Of course the National Association of Realtors are cheerleaders. But the data released by the real estate agent trade group, along with other housing and economic indicators, has turned the opinion of one major Wall Street house. See full story.

The mortgage settlement: A borrower�s guide

The record $26 billion foreclosure-abuse settlement that states and the Obama administration reached last week with five big banks is supposed to help more than 1 million U.S. homeowners. Here are answers to borrower questions about eligibility and whom to contact for help. See full story.

MARKETWATCH COMMENTARY

Instead of acknowledging that banks have become a part of government, we keep pretending they are private institutions, writes David Weidner. See full story.

MARKETWATCH PERSONAL FINANCE

!
Americans are falling behind on savings and need to catch up. Here�s how. See full story.

Tuesday, March 20, 2012

Watch Out! These Municipal Bonds Come With a Bit of a Kick

With high-grade municipal bonds offering meager yields, investors seeking an income jolt are embracing a slightly more exotic product known as "kicker" bonds.
Unlike traditional municipal bonds, which have set term dates of 10 years or more, kicker bonds can be called much sooner and unexpectedly—an unattractive feature for a retiree wanting a set-it-and-forget approach to receiving regular checks. They also sell at a premium to the price investors receive when the bonds mature. But investors get rewarded for that uncertainty—and that premium—with income payouts that can be double those of regular munis, plus the potential for an extra "kick" down the road.
Interest in these bonds waxes and wanes with the state of interest rates, but in today's low-rate climate, they have turned the $3 trillion muni market on its head. Barclays Capital says they now account for 64% of its Municipal Bond index, nearly twice the share from a year ago.
Fans of such premium callable bonds, sometimes called "cushion" bonds, are betting that the Federal Reserve is likely to raise interest rates slowly in coming years. If that happens, kicker bonds could prove a good portfolio protector, says Peter Hayes, head of BlackRock's municipal bond team.
[SMART]
Indeed, the kick comes if for some reason the issuer elects not to call these bonds early—usually because interest rates have risen and refinancing becomes unattractive. In that circumstance, the bond owners get bonus years collecting the higher yield.
Even if the issuer pays back early, the investor will have collected higher payments than with standard ! bonds. " It's kind of a win-win," says John Bonnell, portfolio manager of four municipal bond funds at USAA. "In either scenario you're getting better yield."
However, there is another potential downside for investors: If the bonds are paid back early because of a lower-rate environment, owners could be left holding cash with no good places to put it.
In part for that reason, regular investors have typically shied away from kickers, favoring run-of-the-mill munis for their stability. Demand has helped push the average yield on a Triple-A 10-year muni to a current 1.9% from 3.5% in January 2011, according to Thomson Reuters Municipal Market Data.
But now a growing number of firms, including Deutsche Bank, Wells Fargo and LPL Financial are urging clients to buy kickers instead. Patrick Early, chief municipal analyst with Wells Fargo Advisors, points out that a triple-A rated kicker bond with a 5% coupon would yield about 1.75% if it was called at its first possible chance in six years—almost double that of a current market muni that matures over that period.
Phil Condon, head of municipal bond portfolio management for DWS Investments, says he is selling regular munis to snap up more kicker bonds. He recommends investors look at long-term bonds with 10 years or more between the bond's call date and maturity date. If they aren't called at the first date, Mr. Condon says, the investor will keep collecting the higher interest.

Monday, March 19, 2012

Antiques: The Eye Candy of Investments

Many people consider investing boring. In a sense, it can be. If you don�t have a fever for The Street, you aren�t going to get much out of stocks and bonds other than cold, hard cash. While it�s hard to knock a good return on your investment, some people prefer to put their money in places where it can be enjoyed while it accrues value. The world of antique investing is the perfect market for someone who wants to look at their investment and get joy from it, other than increased value on a balance sheet.

Before You Invest in Antiques

Before you invest in antiques, you need to know the basic lay of the land. Antiques are highly sensitive to market fluctuations, making them a very high-risk form of investing. Whenever you acquire a new piece, you should always buy something that you like and expect to never make a return on your investment. Thus, antique investing is something you do because you love antiques, not because you are looking to make fast money. Instead, you should just hope for the happy accident of acquiring some pieces that are highly collectible. You shouldn�t use antique investing to secure your financial future. In general, you should limit your antique investing to 10 to 15 percent of your overall portfolio.

How To Invest in Antiques

Now that the tough love is over, it�s time to learn about how to invest in the antique market. The key to investing properly is to first educate yourself about the market. You need read books, but you also need to be in the trenches at antique auctions and road shows. Learn about fair prices, but also about what�s actually rare and what�s just cool and old. Focus your educational energies in a few areas that you appreciate and expand from there.
Don�t forget to research antique dealers. Due to the nature of the antique market — the specialized knowledge required to know the difference between a truly exceptional piece and an also-ran — it�s easy for dealers to fleece uneducated customers. Find! a deale r with a good reputation who is happy to educate you as you make your way into the world of antiques collecting. Having a respected dealer also makes your life easier when you go to sell the piece. Your antique will have his explicit seal of approval as a bona fide original, increasing its value on the open market. Talk to other antiques aficionados at the shows and conventions to see who they like dealing with.
Before you go spending money on antiques, take a look at what you have laying around the house. As anyone who has ever seen Antiques Roadshow knows, there are tons of priceless artifacts laying around people�s homes just looking for a buyer. You can convert these into cold, hard cash to pay bills or to begin your foray into the world of antiques investing.

How To Sell Antiques

Of course, an investment only really has value when it comes time to sell. Otherwise, it�s just an asset on a ledger. So, when is the best time to sell an antique? When you�re tired of it, basically. You can watch the market for fluctuations, but just as the best piece to buy is the one you like the best, the best time to sell the piece is when you aren�t quite as infatuated with it as you once were. Before you sell, do some research on the same, or similar, pieces and talk to your antiques dealer. Dealers generally expect you to name your price. If you want to change the piece out for something else, but don�t particularly care about making cash off of it, talk to local antique dealers about making a trade. Many of them can help you exchange the piece you were once in love with for your newest infatuation.

The Beautiful Investment

Again, don�t make any long-term plans for the future based on your antiques collection. Just set aside a part of your portfolio to invest in things you have an interest in. If they turn a profit, consider it a handsome windfall that came out of something you would have purchased anyway.

Sunday, March 18, 2012

S&P Warns Eurozone of Downgrades

Standard & Poor’s warned 15 eurozone nations, including several top-rated ones, that they might be subject to downgrades if a planned summit meeting of eurozone leaders fails to come up with a satisfactory course of action to resolve the bloc’s debt crisis. European Union leaders are scheduled to meet Thursday and Friday to discuss the crisis and strategies to contain it.

The initial report came before the closing bell on Wall Street and sent stocks down from earlier highs. When it was confirmed after the close, Bloomberg reported that bondholders and analysts were critical of the action and its timing. Anthony Valeri, a market strategist with LPL Financial in San Diego, was quoted saying, “S&P should back off. It complicates the job of the EU leaders to resolve the debt problem.”

European Central Bank headquarters (AP photo)The ratings agency warned that top-rated countries including Austria, Belgium, Finland, Germany, the Netherlands and Luxembourg could be in for single-notch downgrades, with France and the others in line for a probably two-notch drop if the summit does not produce a solution that meets S&P’s criteria. In a statement, S&P said in part that “continuing disagreements among European policy makers on how to tackle” the ongoing debt crisis are putting the countries’ financial stability in danger.

The agency’s report said, “The upcoming European summit provides an opportunity for policy makers to break the pattern of what we consider to have been defensive and piecemeal measures to date, overcome individual national interests and preferences, and advance a credible response to the crisis that would go far towards restoring investor confidence.”

European Central Bank Governing Council member Ewald Nowotny of Austria was critical of S&P’s tying the warning to the summit’s outcome. He was quoted saying that the move “highlights the problem that rating agencies increasingly are assuming a political role,” adding, “There is no doubt that rating agencies have an economically important role to play, but the way in which this is happening at the moment is increasingly problematic as it creates pro-cyclical effects; that means effects that make the crises worse.”

S&P, for its part, would only say in a statement that it had decided to review ratings prior to the summit because crisis risks have “risen markedly … Policy makers appear to have acted only in response to mounting market pressures.”

Saturday, March 17, 2012

Best Health Stocks 2012

Last month, the danger of European debt contagion, tensions in Korea, and inflation in China were in focus. But late in January, those concerns gave way to worries over political revolutions in Tunisia and Egypt, and other countries in the Middle East. But crisis creates opportunity, so some North American energy stocks could benefit. In addition, a second U.S. federal judge ruled against the recently enacted health care bill, and there are some companies that stand to benefit from these rulings. That’s why our top stock picks this month are oil stocks and health care stocks.
Where do the markets go from here? So far, stocks appear to be ignoring the inherent danger of a serious crisis in the Middle East even after Moody’s downgraded their rating on Egyptian bonds. But with 8% of the world’s goods and 3.3% of its oil sent through the Suez Canal, there is reason for concern.
Technically the next support for the Dow Industrials is at the 20-day moving average at 11,811 with 11,740 being a stop-loss point for traders. But the zone 11,557 (50-day moving average) to 11,450 is the major support zone and a penetration of that zone would cause a change in trend. A sharp reversal up to a new closing high would negate prior downside reversals. However, increased volatility and heightened political risks make owning domestic oil stocks and health care stocks a common-sense approach to offsetting the current political and investment risks.

Best Health Stocks 2012:Tenet Healthcare Corporation (THC)

 Tenet Healthcare Corporation, an investor-owned health care services company, operates acute care hospitals and related health care facilities. The company?s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive care, critical care and/or coronary care units, physical therapy; and orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, liver, kidney, and bone marrow transplants for children; gamma-knife brain surgery; and cyberknife surgery for tumors and lesions in the brain, lung, neck, and spine. As of June 30, 2011, it operated 49 acute care hospitals, and a critical access hospital with a combined total of 13,420 licensed beds primarily serving urban and suburban communities in 11 states of the United States. The company also owns an interest in a health maintenance organization and operate various related health care facilities, including a long-term acute care hospital and various medical office buildings; revenue cycle management and patient communications services businesses; physician practices; captive insurance companies; and other ancillary health care businesses, such as including ambulatory surgery centers, diagnostic imaging centers, and occupational and rural health care clinics. In addition, Tenet Healthcare Corporation owns an interest in a management services subsidiary that provides network development, utilization management, claims processing, and contract negotiation services to physician organizations and hospitals that assume managed care risk. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Advisors' Opinion:
  • By Sam Collins At 2011-9-11
    Health care services company Tenet Healthcare Corporation (NYSE: THC ) ope! rates 50 general hospitals and a critical access hospital serving urban and rural communities in 12 states. It was recently listed by CNBC as No. 3 on its list of "20 Stocks With the Potential to Pop."
    THC is recommended by 20 analysts with a mean target of $6.96.
    Technically its stochastic issued a buy signal and three recent CBR buys were triggered. A break above $4.60 would yield a target of $6.

Best Health Stocks 2012:Cyanotech Corporation (CYAN)

 Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company?s products include BioAstin natural astaxanthin, a dietary antioxidant for use as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, as well as to enhance skin, muscle, and joint health; and Spirulina Pacifica, a nutrient-rich dietary supplement used for extra energy, as well as used as a strengthened immune system and source of antioxidant carotenoids. It sells its products to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets; and to distributors, retailers, and direct consumers in the form of packaged consumer products. The company markets its products through online, as well as through resellers. Cyanotech Corporation was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

Best Health Stocks 2012:Trinity Biotech plc (TRIB)

 Trinity Biotech plc acquires, develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, sexually transmitted diseases, and autoimmune disorders. It also sells raw materials to the life sciences industry. In addition, the company offers point of care diagnostic tests, which are carried out in the presence of the patient, principally to diagnose the presence of HIV antibodies in the patient. Its customers include hospitals, clinical laboratories, commercial reference laboratories, and research institutions. Trinity Biotech plc sells its products directly, as well as through distributors and strategic partners. The company was founded in 1992 and is headquartered in Bray, Ireland.

Best Health Stocks 2012:Dr. Reddy's Laboratories Ltd (RDY)

 Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec International for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Best Health Stocks 2012:Allergan Inc. (AGN)

 Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.

Best Health Stocks 2012:HMS Holdings Corp (HMSY)

 HMS Holdings Corp. provides cost containment, coordination of benefits, and program integrity services. The company?s services enable clients to recover amounts due from liable third parties, reduce fraud, and ensure regulatory compliance. Its coordination of benefits services route claims paid by a government program to the liable third party, which reimburses the government payor; cost avoidance services provide validated insurance coverage information that is used by government payors to reject claims that are the responsibility of a third party; and program integrity services are designed to identify payment errors and recover the erroneous payments. The company also offers audit programs, program design, benefit management, and general and pharmacy systems consulting services. It serves state Medicaid agencies, Medicaid and Medicare managed care plans, government and private self-funded employers, pharmacy benefit managers, child support agencies, the Veterans Health Administration, the Centers for Medicare and Medicaid Services, commercial plans, healthcare payors and sponsors, business outsourcing and technology firms, and government. The company was founded in 1974 and is headquartered in New York, New York.

Best Health Stocks 2012:Myriad Genetics Inc. (MYGN)

 Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of novel predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. The company markets BRACAnalys medicine test for the treatment of hereditary breast and ovarian cancer; COLARIS molecular test for hereditary colorectal and uterine cancer; COLARIS AP medicine test for the treatment of hereditary colorectal cancer; and MELARIS medicine test to treat hereditary melanoma. It also offers OnDose, a personalized medicine test for colon cancer; PANEXIA, a predictive medicine test for pancreatic cancer; PREZEON, a personalized and prognostic medicine test for cancer; Prolaris, a prognostic medicine test for prostate cancer; and TheraGuide 5-FU, a personalized medicine test for drug toxicity. In addition, the company provides protein analysis services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.

Best Health Stocks 2012:St. Jude Medical Inc. (STJ)

 St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also provides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:
    By Rahemtulla At 2012-2-23 St. Jude Medical(STJ) makes devices for cardiac rhythm management and cardiac surgery. It reported fourth-quarter results last week. St. Jude's adjusted earnings of 75 cents, representing 17% year-over-year growth, exceeded analysts' consensus target by 1.8% and its nearly $1.4 billion of sales beat the consensus by 2.5%, but the stock dropped 1% upon announcement. The operating profit margin dropped from 29% to 25%. Still, return on equity, a key measure of efficiency for stock holders, at 21%, beat the peer group and S&P 500 averages. Jefferies had a positive reaction to the report, noting that St. Jude is poised to gain market share in 2011 on new products. St. Jude has attractive growth rates, having boosted sales and net income 11% and 18% annually, on average, over a three-year span. It is investing heavily in research and development to maintain its above-peer growth. Jefferies forecasts research spending rising from 12% of sales to nearly 13% in 2011. Although this investment spending will hinder margins in the near-term, it will also ensure continuation of St. Jude's robust product pipeline. Bullish Scenario: JPMorgan expects St. Jude to gain 27% to $52. Bearish Scenario: Citigroup predicts a drop of more than 7% to $38.

Best Health Stocks 2012:AmerisourceBergen Corporation (Holding Co) (ABC)

 AmerisourceBergen Corporation, a pharmaceutical services company, provides drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada. The company distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, and long-term care and other alternate site pharmacies. It also offers various services, such as pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting and staffing services, logistics services, and pharmacy management. In addition, AmerisourceBergen provides scalable automated pharmacy dispensing equipment, medication and supply dispensing cabinets, and supply management software to various retail and institutional healthcare providers. Further, the company offers distribution and other services to physicians, who specialize in various disease states; distributes plasma and other blood products, injectible pharmaceuticals, and vaccines; and provides drug commercialization, third party logistics, reimbursement consulting, data analytics, and outcomes research services for biotech and other pharmaceutical manufacturers, as well as practice management and group purchasing services for physician practices. Additionally, it delivers unit dose, punch card, unit-of-use, and other packaging solutions to institutional and retail healthcare providers; and offers contract packaging and clinical trial material services for pharmaceutical manufacturers. The company serves customers through a network of distribution and service centers, and packaging facilities. AmerisourceBergen was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Best Health Stocks 2012:Alexion Pharmaceuticals Inc. (ALXN)

 Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products for treating patients with severe and life-threatening disease states in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on developing products for the treatment of diseases in the areas of hematology, nephrology, neurology, ophthalmology, and cancer. The company develops and commercializes Soliris (eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), a blood disorder. It also conducts various Phase II clinical trail programs on Soliris for its usage for the treatment of cold agglutinin disease; atypical hemolytic uremic syndrome; presensitized renal transplant; kidney transplant for catastrophic antiphospholipid syndrome; ABO incompatible renal transplant; dense deposit disease; myasthenia gravis; neuromyelitis optica; and dry age-related macular degeneration. In addition, the company conducts Phase IV clinical trails on Soliris for its usage for the treatment of PNH registry; and Phase I clinical trails on Samalizumab for the treatment of oncology diseases, such as chronic lymphocytic leukemia and multiple myeloma. Alexion Pharmaceuticals, Inc. serves specialty distributors and specialty pharmacies, which supply physician office clinics, hospital outpatient clinics, infusion clinics, or home health care providers; government agencies; and hospitals, hospital buying groups, pharmacies, other healthcare providers, and distributors. The company was founded in 1992 and is headquartered in Cheshire, Connecticut.
Advisors' Opinion:
  • By Hesler At 2011-8-26
     Alexion Pharmaceuticals Inc. (NASDAQ: ALXN ) specializes in rare and life-threatening diseases. In late June the company initiated a clinical trial of its drug Soliris to see if it could treat the infection behind the German E. coli scare. I! f it suc ceeds, it would be the perfect launching point into the European market. The stock is up 32% since our last issue thanks to strong earnings.

Best Health Stocks 2012:Quality Systems Inc. (QSII)

 Quality Systems, Inc. engages in the development and marketing of healthcare information systems in the United States. The company operates through three divisions: QSI Dental, NextGen, and Practice Solutions. The QSI Dental division develops, markets, and supports software suites for dental and medical practices, as well as supports medical clients that utilize its UNIX based medical practice management software product and Software as a Service based NextDDS financial and clinical software. It also develops, markets, and manages electronic data interchange(EDI)/connectivity applications, as well as QSInet application service provider solutions. The NextGen division offers NextGen ambulatory product suite comprising electronic health records and enterprise practice management solutions; and NextGen inpatient products, including NextGen Clinicals for work efficiency and communication, as well as NextGen Financials, a financial and administrative system. It also offers community connectivity solutions, such as health information exchange, patient portal, and health quality measures; and EDI, hosting, data protection, consulting, and physician resources services. The Practice Solutions division provides technology solutions and consulting services in the areas of revenue cycle management services, including billing and collection services for medical practices. The company?s solutions automate various aspects of medical and dental practices, as well as networks of practices, such as physician hospital organizations and management service organizations, ambulatory care centers, community health centers, and medical and dental schools. Quality Systems was founded in 1974 and is headquartered in Irvine, California.
Advisors' Opinion:
  • By Squeeze Ideas At 2011-8-29
    Healthcare Information Services Industry. Market cap of $2.37B. Short float at 27.58% (equivalent to 31.73 days of average volume).
    Net Income grew by 33.31% ($17.53M vs. $13.15M y/y), while Operating Cash Flow grew by 34.23% ($17.92M vs. $13.35M y/y) (comparing 3 months ending 2010-12-31 vs. 3 months ending 2009-12-31).
    Other Highlights: When compared to industry competitors, the company reported better than average profit margins during the most recent quarter. Gross margins came in at 68.54%, higher than the industry average at 46.33% (most recent quarter, annualized). Operating margin came in at 28.06%, higher than the industry average at 13.44%, while net profit margin came in at 28.06% vs. the industry average at 13.44%.

Friday, March 16, 2012

Are the Earnings at R.R. Donnelley & Sons Hiding Something?

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.
Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on R.R. Donnelley & Sons (Nasdaq: RRD  ) , whose recent revenue and earnings are plotted below.
anImage
Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. FCF = free cash flow. FY = fiscal year. TTM = trailing 12 months.
Over the past 12 months, R.R. Donnelley & Sons generated $464.9 million cash while it booked net income of $231.1 million. That means it turned 4.4% of its revenue into FCF. That sounds OK.
All cash is not equal
Unfortunately, the cash flow statement isn't immune from nonsense, either. That's why it pays to take a close look at the components of cash flow from operations, to make sure that the cash flows are of high quality. What does that mean? To me, it means they need to be real and replicable in the u! pcoming quarters, rather than being offset by continual cash outflows that don't appear on the income statement (such as major capital expenditures).
For instance, cash flow based on cash net income and adjustments for non-cash income-statement expenses (like depreciation) is generally favorable. An increase in cash flow based on stiffing your suppliers (by increasing accounts payable for the short term) or shortchanging Uncle Sam on taxes will come back to bite investors later. The same goes for decreasing accounts receivable; this is good to see, but it's ordinary in recessionary times, and you can only increase collections so much. Finally, adding stock-based compensation expense back to cash flows is questionable when a company hands out a lot of equity to employees and uses cash in later periods to buy back those shares.
So how does the cash flow at R.R. Donnelley & Sons look? Take a peek at the chart below, which flags questionable cash flow sources with a red bar.
anImage
Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. TTM = trailing 12 months.
When I say "questionable cash flow sources," I mean items such as changes in taxes payable, tax benefits from stock options, and asset sales, among others. That's not to say that companies booking these as sources of cash flow are weak, or are engaging in any sort of wrongdoing, or that everything that comes up questionable in my graph is automatically bad news. But whenever a company is getting more than, say, 10% of its cash from operations from these dubious sources, investors ought to make sure to refer to the filings and dig in.
With 11.2% of operating cash flow coming from questionable sources, R.R. Donnelley & Sons investors should take a closer look at the underlying numbers. Within the questionable cash flow figure plot! ted in t he TTM period above, stock-based compensation and related tax benefits provided the biggest boost, at 3.9% of cash flow from operations. Overall, the biggest drag on FCF came from capital expenditures, which consumed 37.4% of cash from operations.
A Foolish final thought
Most investors don't keep tabs on their companies' cash flow. I think that's a mistake. If you take the time to read past the headlines and crack a filing now and then, you're in a much better position to spot potential trouble early. Better yet, you'll improve your odds of finding the underappreciated home-run stocks that provide the market's best returns.
We can help you keep tabs on your companies with My Watchlist, our free, personalized stock tracking service.
  • Add R.R. Donnelley & Sons to My Watchlist.

Thursday, March 15, 2012

Best Wall St. Stocks Today: GOOG,MSFT

When a reporter asked Google Inc. (GOOG) Chief Executive Eric Schmidt recently about whether the search engine giant was making money on the Android mobile phone operating system, he had a strange answer: �Trust me that revenue is large enough to pay for all the Android activities and a whole bunch more.”
Of course, Google does not break out revenue numbers for Android, claiming it is all part of the search business so investors have little choice but to take Schmidt at his word.� His boast may have less to it than meets the eye.
Google spent $898 million on Research and Development in the second quarter.� The company is smart enough not to put all of its eggs in one basket, but it’s probably a safe assumption to assume that Android costs were at least $100 million, which for a company that generated almost $24 billion in sales last year is hardly significant.� Even though sales of Android-powered phones are soaring, Google does not make a dime off them since it gives the OS away for free.
So, how does Google make money off Android?� The same way it’s always done it — advertising.� In theory, someone using their Android-powered phone will be more apt to click on contextual ads that appear after user searches.�� The more devices that have Android, the more likely users will use Google services. How much it will play out in reality is tough to say.� Google already controls by one estimation more than98 percent of the mobile search market.
To be sure,� Android has earned legions of fans and has managed to steal some of the iPhone’s thunder.� Google is banking on the massive scale of Android to generate profit what Dan Frommer at Silicon Alley Insiderdescribes as “a bet on the future of mobile advertising.”
iSuppli estimates that Android will surpass Apple’s share of the smartphone market by 2012 with 75 million Android devices to 62 million for Apple. Moreover, Android’s share will rise to 22.8% of the market in 2014, and! that Ap ple’s iOS will decline to 15.3%.
Schmidt recently told the�Wall Street Journal:�If we have a billion people using Android, you think we can�t make money from that?�� He estimated that mobile devices could be a $10 billion business for Google without providing specifics such as how or when.� Google does have a history of creating services that people like.
Gmail and Google Docsare gaining share at the expense of Microsoft Corp. (MSFT). Google Maps probably has overtaken MapQuest.� Google’s instant messaging service Google Talk also is popular.� None of them has added much to Google’s bottom line.� Some competitors such as Microsoft CEO Steve Ballmer have questioned how Google will ever make money with Android. He has a point.
And perhaps further evidence that Google will spend money without a business plan, Direct� TV has announced that the search giant will begin selling ads on channels including Bloomberg, Fox Business, Centric, Fuel, G4, Ovation, Fit, Sleuth, Chiller and TV Guide.
Even though Android is a great product, that does not mean it’s a profitable one.
-Jonathan Berr

Wednesday, March 14, 2012

Best Wall St. Stocks Today: JCP

Moody’s Investors Service put the heat on the credit ratings of J.C. Penney Co. (NYSE: JCP).� While a cut in the retail sector may not be anything shocking in this climate, this downgrade took the company to “junk” status. The company’s senior unsecured notes were cut by one notch to “Ba1″ from “Baa3.”

Moody’s also believes that the operating results are likely to decline further this year and should remain below historic levels in the near-term to medium-term horizons.
Moody’s had already fired a shot across their bow in February with a note that it was going to review the ratings for a possible cut.� Moody’s believes that weaker performance will lead to J.C. Penney’s credit metrics falling.
Noted was the significant softness in sales, but it was also noted that the company is taking steps to reduce inventory to levels which may prevent massive markdowns which were seen in recent months and in 2008.
Moody’s did say that the company is currently seeking commitments for a senior secured credit facility to replace its existing $1.2 billion unsecured pact.� While credit metrics are expected to erode to levels more
appropriate for a “mid-Ba rating,” its liquidity and conservative financial policies did give Moody’s comfort that it can weather the current economic storm.
So far shares do not seem to be bothered.� J.C. Penney stock is up 1.5% at $20.38 on the day.� Its 52-week range if $13.71 to $46.56.
Jon C. Ogg
April 1, 2009

Tuesday, March 13, 2012

Wall Street Needs to Get Behind These Stocks

Wall Street doesn't seem to think the companies listed below worth much enthusiasm. So why do our Motley Fool CAPS members disagree? They've bestowed on these companies the highest four- and five-star ratings, signaling their faith that the associated businesses will outperform the market while Wall Street offers lackluster support at best.
So who�has it right? The professional class of analysts sitting in their paneled offices smoking stogies, or a motley crew of community investors pooling their best thoughts for others to share? We think we know who'll come out ahead. How about you?
Stock
CAPS Rating (out of 5)
No. of Analysts
Wall Street Bullish Sentiment
CAPS Bullish Sentiment
Computer Sciences (NYSE: CSC  ) **** 11 63% 87%
GlaxoSmithKline (NYSE: GSK  ) **** 16 69% 95%
Source: Motley Fool CAPS.
Now, as much as we love our CAPS community, don't buy these companies just because they've garnered top ratings. And don't sell 'em just because Wall Street says to, either. Investing requires close diligence on your part, so use these ratings as a launching pad for your own research.
The "It" girl
It's understandable why analysts are reticent about backing IT services specialist Computer Sciences. It's still under investigation by the SEC over accounting irregularities i! n some o f its international divisions; it is still weighed down by its contract dispute with the health services regulator in the U.K., something that could cause it to write down the $1.5 billion full value of the contract; and its CFO just resigned in the wake of the company's appointment of a new CEO.
It's actually that last point that probably portends the most hope for the government IT contractor. A fresh start with fresh eyes can sometimes be what a company needs to get past an ugly chapter in its history. Rival Ebix (Nasdaq: EBIX  ) has bounced back after questions were raised over its accounting propriety and its�growth-by-acquisition strategy. Shares of the cloud-based IT coordinator have climbed back up to nearly the same level they were at a year ago despite having been cut in half by this past October.
Computer Sciences reported earnings that beat analyst expectations, once adjustments were made to exclude the NHS contract. It also reported that new contract business stood at $13 billion year to date, up 26% from the year-ago period, so with a turnaround specialist at the helm now, there seems every reason to believe it can continue to improve, even if the big rally in shares the other day was a bit premature.
While the broader CAPS community is supportive of CSC, All-Star CAPS members are even more so, with 90% of those top investors weighing in thinking it will go on to outperform the broad indexes. Add the IT specialist to�your Watchlist�then head over to the�Computer Sciences CAPS page�and tell us if you think the turnaround around specialist can turn around CSC.
At the precipice
Pharmaceutical giant GlaxoSmithKline suffered something of the opposite problem the other day when it reported earnings. While it was profitable, it missed analyst projections and saw sales of its Avandia and Valtrex slip. It also said it was buying back less stock than it did a year ago.
Unlike some rival drug mak! ers like Eli Lilly (NYSE: LLY  ) and AstraZeneca (NYSE: AZN  ) , who face a particularly steep patent cliff, wherein a significant portion of their revenue will face generic competition in the near future, Glaxo hopes to achieve something more akin to a "patent slope." That's because it has a deep pipeline of drugs in development that ought to help make up for the loss of protection for Seretide and Avandia.
CAPS member BinyaminK recently remarked that Glaxo is a slow and steady performer that, like the tortoise in its race against the hare, should ultimately come out ahead.
This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.
Add GlaxoSmithKline to the Fool's free portfolio tracker and see if it can coast over the edge with the rest of the pharmaceutical industry.
What's wrong with that?
Banking stocks are indeed scary places to invest these days, but find out the one financial institution The Motley Fool believes even Warren Buffett would consider taking a stake in if he could. Get your copy of the special free report "The Stocks Only the Smartest Investors Are Buying" before this limited-time offer expires.

Monday, March 12, 2012

Cintas Passes This Key Test

There's no foolproof way to know the future for Cintas (Nasdaq: CTAS  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
A cloudy crystal ball
In this series, we use accounts receivable and days sales outstanding to judge a company's current health and future prospects. It's an important step in separating the pretenders from the market's best stocks. Alone, AR -- the amount of money owed the company -- and DSO -- the number of days' worth of sales owed to the company -- don't tell you much. However, by considering the trends in AR and DSO, you can sometimes get a window onto the future.
Sometimes, problems with AR or DSO simply indicate a change in the business (like an acquisition), or lax collections. However, AR that grows more quickly than revenue, or ballooning DSO, can also suggest a desperate company that's trying to boost sales by giving its customers overly generous payment terms. Alternately, it can indicate that the company sprinted to book a load of sales at the end of the quarter, like used-car dealers on the 29th of the month. (Sometimes, companies do both.)
Why might an upstanding firm like Cintas do this? For the same reason any other company might: to make the numbers. Investors don't like revenue shortfalls, and employees don't like reporting them to their superiors.
Is Cintas sending any potential warning signs? Take a look at the chart below, which plots revenue growth against AR growth, and DSO:
anImage
Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. FQ = fiscal quarter.
The standard way to calculate DSO uses average accounts receivable. I prefer to look at end-of-quarter receivables, but I've plo! tted bot h above.
Watching the trends
When that red line (AR growth) crosses above the green line (revenue growth), I know I need to consult the filings. Similarly, a spike in the blue bars indicates a trend worth worrying about. Cintas' latest average DSO stands at 39.6 days, and the end-of-quarter figure is 39.9 days. Differences in business models can generate variations in DSO, and business needs can require occasional fluctuations, but all things being equal, I like to see this figure stay steady. So, let's get back to our original question: Based on DSO and sales, does Cintas look like it might miss it numbers in the next quarter or two?
I don't think so. AR and DSO look healthy. For the last fully reported fiscal quarter, Cintas' year-over-year revenue grew 8.8%, and its AR grew 11.2%. That looks OK. End-of-quarter DSO increased 2.2% over the prior-year quarter. It was about the same as the prior quarter. Still, I'm no fortuneteller, and these are just numbers. Investors putting their money on the line always need to dig into the filings for the root causes and draw their own conclusions.
What now?
I use this kind of analysis to figure out which investments I need to watch more closely as I hunt the market's best returns. However, some investors actively seek out companies on the wrong side of AR trends in order to sell them short, profiting when they eventually fall. Which way would you play this one? Let us know in the comments below, or keep up with the stocks mentioned in this article by tracking them in our free watchlist service, My Watchlist.
  • Add Cintas to My Watchlist.

Stock Market Buying Power Hits New Rally High, as Demand Outpaces Supply

By : Teakcenter2607/TeakFurniture
Right now there occurs an occasion in each and every man’s existence whenever he will probably always be contacted to supply his view regarding home furniture. This specific inanimate object might turn into brand-new inclusion to be able to his surroundings, or even worse, it could be replacing an additional bit of that she may possibly are getting to be rather accustomed far too. For that reason, it has to be his duty at the least to be able to say that he is a good little considering what is going on, in any other case to please someone else, to be able to at the least copy his sudden display associated with nobility when confronted with needless transform.
The first way this really is achieved should be to manage the matter associated with dimensions whenever coming to a choice in regards to a brand-new piece of furniture teak furniture manufacturers. Go on a your bed as an example, there is a sensible chances anytime your sweet heart is looking throughout the magazine, or browsing the web, she’ll always be concentrating on the particular visual areas of the particular bit. Straightener or lumber? Twice or king-size? Four-poster? This really is sensible, first thing any individual gives discern each item from an additional – if you’re looking over more than a webpage – should be to detect the direction they seem. Well you can part of previous to she gets to be able to dimensions. Simply how much room have you got to do business with length-wise, width-wise in addition to height-wise? Can you perhaps understand it inside the stairways? And say you do not experience virtually any possiblity to find your own tape-measure teak furniture manufacturers.
The 2nd factor to grasp by incorporating passion is the case of toughness. Understand your own components. Understand your own fittings far too. Have you heard of designed obsolescence? Don’t forget this key phrase – and use it if you wish to feel lik! e what h appens you will be discussing. So will this tree keep going longer than beech? Or maybe will certainly MDF or chipboard complete? After all you don’t want to stay in this position yet again within twenty years’ period. As well as how is the particular bit about to fit together, or fit to be able to something else entirely whether it would need to? Generally speaking, really don’t anticipate a thing that requires Allen secrets to final. And believe in a thing that provides a tool-kit is included. (And teak furniture manufacturers. b. this can be the perfect time and energy to acquire some honorable brownie things).
A different authentic strategy to reveal that you’re interested should be to pinpoint the functionality in the bit. There’s a chance nevertheless that can easily backfire, using the fully possible result of verbal neglect amounting to be able to something similar to the next: ‘Lighten upwards McPractical, that will wide screen Television set isn’t sensible!I Thus proper care does need to be consumed. Merely try and concentrate on exactly how very well it is going to function the woman desires and you will be very good.
With these instruction at heart, and a amount of exercise, you won’t check out a new dresser exactly the same yet again.
For a selection of goods from pcs to be able to gardening equipment, home furniture, underwear by means of jewelry to be able to garments or a some poster your bed, Searching.org is a superb path to finding products on-line, in addition to incorporates reviews.

Sunday, March 11, 2012

Global gains from high yield corporates

AllianceBernstein Global High Income Fund (AWF) is a closed-end fund that invests primarily in high-yield corporate bonds and, to a lesser extent, emerging market sovereign debt.

High-yield debt consists of bonds issued by companies or governments that are rated below investment grade by the major credit ratings agencies such as Standard & Poor's and Moody's.

Roughly two-thirds of the fund's holdings are rated below investment grade, and the average coupon rate of the fund's bond holdings is just over 8.5%.

Companies and governments rated below investment grade carry higher credit risk, meaning that the odds they'll be unable to repay their borrowings are theoretically higher than for a company carrying an investment-grade credit rating.

Since the risk of default is higher, high-yield bonds tend to carry higher interest rates than investment-grade debt, a means of compensating investors for the extra risk they're taking.
With rates in the investment grade corporate and government bond markets so low, investors have been looking for higher-yielding alternatives, including high-yield debt. That's powered a significant rally in the exact sort of bonds that AWF focuses on.

For example, the fund's largest holding is a bond issued by the Argentinean government that matures in October 2015 that currently yields around 9%. Argentina has a credit rating of "B" from Standard & Poor's and "B3" from Moody's, several steps below investment grade.

There's no doubt the country has its share of economic and political problems. But Argentina's sovereign debt has seen a significant rally since August as investors are attracted to its high yields and solid economic fundamentals.

AWF's second-largest holding is a series of corporate bonds issued by Russi! an Agric ultural Bank that are rated "BBB", the lowest possible investment-grade credit rating.

While banks in the U.S. and Europe have been troubled in recent years by bad loans made to residential homebuyers and shaky E.U. countries, Russian banks have relatively clean balance sheets.

Russia is a major exporter of natural gas, oil, coal and other commodities and continues to benefit from strong demand and pricing for its natural resources.

And the fund has little exposure whatsoever to debt issued by corporates or governments in fiscally challenged E.U. nations. Only around 0.5% of the fund's total portfolio is invested in bonds issued by Italian firms.

AWF pays a $0.10 monthly distribution, equivalent to a yield of roughly 8.4% at current prices.

Action to Take --> With a well-diversified portfolio of high-yield bonds offering a yield over 8%, AllianceBernstein Global High Income Fund is a solid buy candidate with moderate risk.

Saturday, March 10, 2012

Mattel Reports Third Quarter 2011 Financial Results


– Declares Quarterly Dividend and Increases Share Repurchase Program by $500 Million –
Third Quarter Highlights
Worldwide net sales up 9 percent;
Domestic gross sales up 6 percent and international gross sales up 13 percent;
Worldwide gross sales for core brands: Barbie(R) up 17 percent; Hot Wheels(R) up 6 percent; Core Fisher-Price(R) up 5 percent and American Girl(R) brands up 4 percent;
Gross margin decreased 330 basis points of net sales; SG&A decreased 370 basis points of net sales;
Operating income of $397.6 million compared to operating income of $358.6 million in the third quarter of 2010; and
Earnings per share of $0.86 vs. prior year earnings per share of $0.77 (which included a tax benefit of $0.05).

Capital Deployment
Board declares fourth quarter cash dividend of $0.23 per share, reflecting an annualized dividend of $0.92 per share, which represents an 11 percent increase to last year�s annual dividend;
The company repurchased 6.6 million shares of its common stock at a cost of approximately $173 million; and
Board authorizes the company to increase its previously announced share repurchase program by $500 million.

EL SEGUNDO, Calif–(CRWENEWSWIRE) — Mattel, Inc. (NASDAQ:MAT) today reported 2011 third quarter financial results. For the quarter, the company reported net income of $300.8 million, or $0.86 per share, compared to last year�s third quarter net income of $283.3 million, or $0.77 per share.
�We continue to be pleased with our performance across our portfolio of brands in all of the regions of the world. Not only have we continued to benefit from the strength of our core brands, but this year�s big entertainment property, CARS 2(R), is also fueling momentum,� said Robert A. Eckert, chairman and chief! executi ve officer of Mattel. �As we enter into the all-important holiday season, we remain keenly focused on execution and delivering growth in our core brands, working to expand and leverage our international footprint, optimizing our entertainment portfolio, and building our newest franchise, Monster High.�
Financial Overview
For the quarter, net sales were $2.0 billion, up 9 percent compared to $1.83 billion last year, including favorable changes in currency exchange rates of 2 percentage points. On a regional basis, third quarter gross sales increased 6 percent in the U.S. and increased 13 percent in international markets, including favorable changes in currency exchange rates of 5 percentage points. Operating income for the quarter was $397.6 million, compared to prior year�s operating income for the quarter of $358.6 million.
The company�s debt-to-total-capital ratio was 33.0 percent. Consistent with the seasonality of the business, net cash flows used for operating activities were approximately $322 million in the first nine months of 2011, a decrease of $106 million, compared with a use of approximately $428 million in the same period in 2010.
Cash flows used for financing and other activities were $586 million in the first nine months of 2011, compared to cash flows from financing and other activities of approximately $361 million in the same period in 2010, primarily reflecting increased debt repayments consistent with scheduled maturities, dividend payments and increased share repurchases in 2011, as well as the issuance of $500 million of senior unsecured notes in the third quarter of 2010.
During the third quarter of 2011, the company repurchased approximately 6.6 million shares of its common stock at a cost of approximately $173 million.
Sales by Business Unit
Mattel Girls and Boys Brands
For the third quarter, worldwide gross sales for the Mattel Girls & Boys Brands business unit were $1.34 billion, up 15 percen! t versus a year ago. Worldwide gross sales for the Barbie(R) brand were up 17 percent. Worldwide gross sales for Other Girls Brands were up 32 percent, driven by the Monster High(R) and Disney Princess� doll lines. Worldwide gross sales for the Wheels business, which includes the Hot Wheels(R), Matchbox(R) and Tyco R/C(R) brands, were up 2 percent. Worldwide gross sales for the Entertainment business, which includes Radica(R) and Games and Puzzles, were up 14 percent for the quarter, primarily driven by growth in the CARS 2(R) property.
Fisher-Price Brands
Third quarter worldwide gross sales for the Fisher-Price(R) Brands business unit, which includes the Fisher-Price(R) Core, Fisher-Price(R) Friends and Power Wheels(R) brands, were $748.9 million, up 1 percent versus the prior year, primarily driven by sales of Infant products.
American Girl Brands
Third quarter gross sales for the American Girl(R) Brands business unit, which offers American Girl(R) branded products directly to consumers, were $87.6 million, up 4 percent versus last year, primarily reflecting sales of products related to Kanani�, the 2011 Girl of the Year(R).
Quarterly Dividend
Additionally, the company announced today that its Board of Directors declared a fourth quarter cash dividend of $0.23 per share on the Company�s common stock. The dividend will be payable on December 16, 2011 to stockholders of record on November 30, 2011. The dividend is the fourth of four quarterly dividends the Company will pay this year, reflecting an annualized dividend of $0.92 per share, which represents an increase of $0.09 per share, or 11 percent, versus last year�s annual dividend of $0.83 per share.
Increase in Share Repurchase Program
The Mattel Board of Directors authorized the company to increase its previously announced share repurchase program by $500 million. Repurchases will take place from time to time, depending on market conditions.
The share repurchase program is one component ! of the c ompany�s capital and investment framework which was announced in February 2003. Under the program, Mattel has repurchased approximately 144.7 million shares of its common stock for an aggregate of approximately $3.0 billion.
Live Webcast
Mattel will webcast its 2011 third quarter financial results conference call at 8:30 a.m. Eastern time today. The conference call will be webcast on the �Investors & Media� section of the company�s corporate Web site: http://corporate.mattel.com/. To listen to the live call, log on to the Web site at least 15 minutes early to register, download and install any necessary audio software. An archive of the webcast will be available on the company�s Web site for the next 90 days and may be accessed beginning two hours after the completion of the live call. A telephonic replay of the call will be available beginning at 11:30 a.m. Eastern time on October 14 until Tuesday, October 18, at midnight Eastern time and may be accessed by dialing +1-404-537-3406. The passcode is 99034862.
Information required by Securities and Exchange Commission Regulation G, regarding non-GAAP financial measures, as well as other financial and statistical information, will be available at the time of the webcast on the �Investors & Media� section of http://corporate.mattel.com/, under the sub-headings �Financial Information� � �Earnings Releases.�
About Mattel
Mattel, Inc. (www.mattel.com) is the worldwide leader in the design, manufacture and marketing of toys and family products. The Mattel family comprises such best-selling brands as Barbie(R), the most popular fashion doll ever introduced, Hot Wheels(R), Matchbox(R), American Girl(R), Radica(R) and Tyco R/C(R), as well as Fisher-Price(R) brands, including Little People(R), Power Wheels(R) and a wide array of entertainment-inspired toy lines. In 2011, Mattel was named as one of FORTUNE Magazine�s �100 Best Companies to Work F! or� for the fourth year in a row, and was also ranked among Corporate Responsibility Magazine�s �100 Best Corporate Citizens.� With worldwide headquarters in El Segundo, Calif., Mattel employs approximately 31,000 people in 43 countries and territories and sells products in more than 150 nations. At Mattel, we are �Creating the Future of Play.� Follow Mattel on Facebook: www.facebook.com/mattel
Note: This press release contains forward-looking statements relating to the Company�s expected 2011 financial performance. These forward-looking statements are based on currently available operating, financial, economic and other information and are subject to a number of significant risks and uncertainties. A variety of factors, many of which are beyond our control, could cause actual future results to differ materially from those projected in the forward-looking statements. Some of these factors are described in the Company�s periodic filings with the Securities and Exchange Commission, including the �Risk Factors� section of Mattel�s Annual Report on Form 10-K for the fiscal year ended December 31, 2010 and Mattel�s Quarterly Reports on Form 10-Q for fiscal year 2011, as well as in Mattel�s other public statements. Mattel does not update forward-looking statements and expressly disclaims any obligation to do so.

< td>!
MATTEL, INC. AND SUBSIDIARIESEXHIBIT I
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
For the Three Months Ended September 30,For the Nine Months Ended September 30,
(In millions, except per share and percentage information)
20112010Yr / Yr % Change20112010Yr / Yr % Change
$ Amt% Net Sales$ Amt% Net Sales$ Amt% Net Sales$ Amt% Net Sales
Net Sales$1,998.8$1,833.19%$4,112.3$3,731.610%
Cost of sales1,042.752.2%895.6 48.9%16%2,126.851.7%1,872.650.2%14%
Gross Profit956.147.8%937.551.1%2%1,985.548.3%1,859.049.8%7%
Advertising and promotion expenses219.911.0%201.611.0%9%437.910.6%397.710.7%10%
Other selling and administrative expenses338.616.9%377.320.6%-10%1,004.024.4%988.026.5%2%
Operating Income397.619.9%358.619.6%11%543.613.2%473.312.7%15%
Interest expense15.40.8%13.80.8%11%51.81.3%40.91.1%27%
Interest (income)(1.1)-0.1%(1.8)-0.1%-42%(6.7)-0.2%(7.1)-0.2%-6%
Oth! er non-o perating (income), net(2.4)-(3.3)(2.5)
Income Before Income Taxes385.719.3%346.618.9%11%501.812.2%442.011.8%14%
Provision for income taxes84.963.3103.982.3
Net Income$300.815.0%$283.315.5%6%$397.99.7%$359.79.6%11%
EPS - Basic$0.87$0.78$1.14$0.98
Average Number of Common Shares343.2360.6346.4362.2
EPS - Diluted$0.86$0.77$1.12$0.97
Average Number of Common and Potential Common Shares
346.8363.5350.0365.4
< td class="bwpadl0 bwnowrap bwpadr0 bwvertalignb bwalignl">%
MATTEL, INC. AND SUBSIDIARIESEXHIBIT II
WORLDWIDE GROSS SALES INFORMATION (Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
(In millions, except percentage information)2011201020112010
Worldwide Gross Sales:
Mattel Girls & Boys Brands$1,343.1$1,169.1$2,795.1$2,395.4
% Change
15%8%17%13%
Pos./(Neg.) Impact of Currency (in % pts)
4-44-2
Fisher-Price Brands748.9743.41,458.81,444.7
% Change
1%-5%1%0%
Pos./(Neg.) Impact of Currency (in % pts)
1-22-2
American Girl Brands87.684.4227.0213.5
% Change
4%2%6%2%
Other3.6-7.65.6
Gross Sales$2,183.2$1,996.9$4,488.5$4,059.2
% Change
9%2%11%7%
Pos./(Neg.) Impact of Currency (in % pts)2-33-2
Reconciliation of Non-GAAP to GAAP Financial Measure:
Gross Sales$2,183.2$1,996.9$4,488.5$4,059.2
Sales Adjustments(184.4)(163.8)(376.2)(327.6)
Net Sales$1,998.8$1,833.1$
4,112.3
$3,731.6
% Change
92%10%7%
Pos./(Neg.) Impact of Currency (in % pts)2-33-1
MATTEL, INC. AND SUBSIDIARIES
EXHIBIT III
CONDENSED CONSOLIDATED BALANCE SHEETS
At September 30,At Dec. 31,
2011 20102010
(In millions)
(Unaudited)
Assets
Cash and equivalents$254.5$960.5$1,281.1
Accounts receivable, net1,650.61,550.01,146.1
Inventories764.0741.4463.8
Prepaid expenses and other current assets303.7313.8335.6
Total current assets2,972.83,565.73,226.6
Property, plant and equipment, net515.3478.1484.7
Other noncurrent assets1,713.41,715.01,706.4
Total Assets$5,201.5$5,758.8$5,417.7
Liabilities and Stockholders’ Equity
Short-term borrowings$236.8$5.5$-
Current portion of long-term debt60.0250.0250.0
Accounts payable and accrued liabilities1,055.91,138.11,048.5
Income taxes payable45.752.251.8
Total current liabilities1,398.41,445.81,350.3
Long-term debt900.0960.0950.0
Other noncurrent liabilities472.6495.9488.8
Stockholders’ equity2,430.52,857.12,628.6
Total Liabilities and Stockholders’ Equity$5,201.5$5,758.8$5,417.7
SUPPLEMENTAL BALANCE SHEET AND CASH FLOW ! DATA (Un audited)
At September 30,
(In millions, except days and percentage information)
20112010
Key Balance Sheet Data:
Accounts Receivable, Net
Days of Sales Outstanding (DSO)7476
Total Debt Outstanding$1,196.8$1,215.5
Total Debt-to-Total-Capital Ratio33.0%29.8%
Nine Months Ended September 30,
(In millions)
2011 (a)2010
Condensed Cash Flow Data:
Cash Flows (Used For) Operating Activities$(322)$(428)
Cash Flows (Used For) Investing Activities(119)(89)
Cash Flows (Used For) Provided By Financing Activities and Other(586)361
Decrease in Cash and Equivalents$(1,027)$(156)
(a) Amounts shown are preliminary estimates. Actual amounts will be reported in Mattel’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.

Contact:

Mattel, Inc.News Media:Lisa Marie Bongiovanni, 310-252-3524LisaMarie.Bongiovanni@mattel.comSecurities Analysts:Drew Vollero, 310-252-2703Drew.Vollero@mattel.com



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!